Distribution of Ra-226, Th-232 and K-40 in soils and sugar cane crops at Corumbatai river basin, São Paulo State, Brazil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Doses from Rn-222, Ra-226, and Ra-228 in groundwater from Guarani aquifer, South America

Groundwater samples were analysed for Rn-222, Ra-226, and Ra-228 in Guarani aquifer spreading around I million kin 2 within four countries in South America, and it was found that their activity concentrations are lognormally distributed. Population-weighted average activity concentration for these radionuclides allowed to estimate a value: either slightly higher (0.13 mSv/year) than 0.1 mSv for the total effective dose or two times higher (0.21 mSv/year) than this limit, depending on the choice of the dose conversion factor. Such calculation adds useful information for the appropriate management of this transboundary aquifer that is socially and economically very important to about 15 million inhabitants living in Brazil, Argentina, Uruguay and Paraguay. (C) 2004 Elsevier Ltd. All rights reserved.

A method for evaluating Ra-228 in environmental matrices and its use at Pocos de Caldas plateau, Brazil

This work describes a methodology developed for performing the extraction, detection and quantification of Ra-228 in waters, suspended solids and sediments. The technique proved to be useful for analyzing samples from the hydrological environment of Morro do Ferro, Pocos de Caldas plateau, Brazil. The 228Ra activity in underground waters of 5 boreholes drilled in the area varied from 0.02 up to 14.5 Bq/l, whereas for the surficial waters the variation was from 0.04 to 0.51 Bq/l; for the suspended solids, the values ranged from 1.5 up to 419 Bq/g, whereas it was possible to find a value of 2.04 Bq/g for the sediments. These results show the applicability of the method for characterizing different matrices of environmental interest. (C) 2002 Elsevier B.V. Ltd. All rights reserved.

AR | RA: a arte na realidade aumentada

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Respostas inflamatória, hematológica, de estresse oxidativo, prejuízo muscular e composição corporal em ultramaratona de 217 km

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

MVC-RA: múltiplas visões coordenadas em ambientes de realidade aumentada

Versa sobre a aplicação das características de um ambiente de realidade aumentada, tais como: interação fácil e intuitiva, e grande espaço para visualização de dados, na implementação, interação e visualização de múltiplas visões de dados coordenadas. As múltiplas visões de dados permitem que o usuário realize uma melhor análise dos dados sobre diferentes aspectos, e a coordenação entre as múltiplas visões tem o objetivo de diminuir a sobrecarga oogniriva conferida ao usuário. O ambiente aumentado foi concebido através do ARToolKit, a interação se dá através de uma interface baseada em cartões marcadores. A técnica implementada foi Dispersão de Dados 3D, acompanhada de uma diversidade de filtros e configurações para as visões de dados. Por fim, são apresentados alguns ensaios de usabilidade preliminares do protótipo desenvolvido.

Rn-222, Ra-226 and hydrochemistry in the Bauru Aquifer System, Sao Jose do Rio Preto (SP), Brazil

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Ra-226 and Ra-228 in mineral waters of southeast Brazil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Exá raú mboguatá guassú mohekauka yvy marãe‟y

Resumo: O presente estudo procura analisar sob as lentes da antropologia, a forma como as lideranças religiosas Mbya, cumprem os sonhos recebidos de Nhanderú Ete, iniciando a caminhada em direção a terra sem mal, a yvy marãe‟y; retornam ao local de ocupação antiga ou a indicada por Nhanderú, terra com a qual mantém laços históricos de luta. Os conflitos se intensificam com a demarcação/ampliação dos territórios ou de terra para o Guarani Mbya, como no caso do Pará, que andaram por cerca de cem anos até encontrar a terra onde exercitar o modo correto de se viver; o dissenso potencializa o etnocentrismo, a discriminação, o racismo, o estigma de ser índio, bugre, preguiçoso, alcoólatra, “raça inferior”. A pesquisa versa sobre o modo como "escolhem”, “adotam,” “retomam,” ressignificam, reterritorializam, guaranizam a terra onde pausaram a caminhada.

RP92-217 #2 Producer Marketing Mangement: Deferred Pricing Alternatives for Grain

Grain producers must make marketing decisions every day. First they must decide whether to price or hold grain. If they decide to price grain, they must then choose the most appropriate method of pricing: cash sale, forward contract, or hedging. If they decide to hold grain (not to price), they must choose the most appropriate method of retaining ownership. This fact sheet presents some guidelines to help producers choose the least costly method of owning grain or speculating on price level changes.

RP94-217 No. 18 Use of Crop Futures and Options by the Nontrader

Crop producers make a number of decisions that are market related. They may be categorized as financial decisions, production decisions, or marketing decisions. All three decisions depend on what prices are likely to be at some specific time in the future. The marketing decisions is complex. This research publication discusses the number of alternatives that are available even for the producer who does not directly buy or sell futures or options contracts.

RP92-217 No. 19 Cost of Grain Storage

Grain marketing decisions are among the toughest the farm owner/operator or manager must make. Grain producers store grain to speculate on receiving higher prices, earn a return above storage costs, or to take advantage of government programs. Prices must increase enough to cover the additional costs, or forward contract prices must exceed current prices by more than the cost of storage in order to justify forward pricing. The gain in prices received can come from both changes in price level and changes in basis. This research publication discusses all the areas of the cost of grain storage.

The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years

Autoantibodies in early rheumatoid arthritis (RA) have important diagnostic value. The association between the presence of autoantibodies against cyclic citrullinated peptide and the response to treatment is controversial. To prospectively evaluate a cohort of patients with early rheumatoid arthritis (< 12 months of symptoms) in order to determine the association between serological markers (rheumatoid factor (RF), anti-citrullinated protein antibodies) such as anti-cyclic citrullinated peptide antibodies (anti-CCP) and citrullinated anti-vimentin (anti-Sa) with the occurrence of clinical remission, forty patients diagnosed with early RA at the time of diagnosis were evaluated and followed for 3 years, in use of standardized therapeutic treatment. Demographic and clinical data were recorded, disease activity score 28 (DAS 28), as well as serology tests (ELISA) for RF (IgM, IgG, and IgA), anti-CCP (CCP2, CCP3, and CCP3.1) and anti-Sa in the initial evaluation and at 3, 6, 12, 18, 24, and 36 months of follow-up. The outcome evaluated was the percentage of patients with clinical remission, which was defined by DAS 28 lower than 2.6. Comparisons were made through the Student t test, mixed-effects regression analysis, and analysis of variance (significance level of 5%). The mean age was 45 years, and a female predominance was observed (90%). At the time of diagnosis, RF was observed in 50% of cases (RF IgA-42%, RF IgG-30%, and RF IgM-50%), anti-CCP in 50% (no difference between CCP2, CCP3, and CCP3.1) and anti-Sa in 10%. After 3 years, no change in the RF prevalence and anti-CCP was observed, but the anti-Sa increased to 17.5% (P = 0.001). The percentage of patients in remission, low, moderate, and intense disease activity, according to the DAS 28, was of 0, 0, 7.5, and 92.5% (initial evaluation) and 22.5, 7.5, 32.5, and 37.5% (after 3 years). There were no associations of the presence of autoantibodies in baseline evaluation and in serial analysis with the percentage of clinical remission during follow-up of 3 years The presence of autoantibodies in early RA has no predictive value for clinical remission in early RA.